SEC Comment Letter 0000000000-23-013319 to IRONWOOD PHARMACEUTICALS INC (IRWD) (CIK 0001446847) (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD) (CIK 0001446847)
Date: Dec. 6, 2023 · CIK: 0001446847 · Accession: 0000000000-23-013319
AI Filing Summary & Sentiment
File numbers found in text: 001-34620
Letter
United States securities and exchange commission logo December 6, 2023 Sravan K. Emany Chief Financial Officer Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston, MA 02110 Re:Ironwood Pharmaceuticals, Inc. Form 10-K for Fiscal Year Ended December 31, 2022 File No. 001-34620 Dear Sravan K. Emany: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
December 6, 2023
Sravan K. Emany
Chief Financial Officer
Ironwood Pharmaceuticals, Inc.
100 Summer Street, Suite 2300
Boston, MA 02110
Re:Ironwood Pharmaceuticals, Inc.
Form 10-K for Fiscal Year Ended December 31, 2022
File No. 001-34620
Dear Sravan K. Emany:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences